Jan. 8, 2024 7:58 am ET

Boston Scientific will acquire Axonics for about $3.7 billion in cash.

The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.

Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

PG&E Warns of More Blackouts During California’s Wildfire Season

PG&E Corp. said it is likely to proactively cut power to customers…

San Francisco sues its own school district, demands restart of in-person instruction

In what could be the nation’s first such case, the city of…

Texas, parts of South brace for next round of winter weather

Millions in Texas were without power early Wednesday amid winter weather, bitter…

Congress overrides Trump’s veto for the first time on major military bill

WASHINGTON — The Senate on Friday joined the House to override President…